Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study

MLA

S. Velasco, et al. “Immunohistochemical Evaluation of Two Antibodies against PD-L1 and Prognostic Significance of PD-L1 Expression in Epithelioid Peritoneal Malignant Mesothelioma: A RENAPE Study.” European Journal of Surgical Oncology (EJSO), vol. 43, Oct. 2017, pp. 1915–23. EBSCOhost, https://doi.org/10.1016/j.ejso.2017.05.009.

APA

S. Velasco, M. Chassang, Laurence Gladieff, Jean-Marc Guilloit, Frédéric Dumont, Thomas Courvoisier, Magali Svrcek, E. Mery, Jack Porcheron, Pablo Ortega-Deballon, V. Barrau, M. Serrano, Pierre Meeus, H. Senellart, Cécile Brigand, R. Kianmanesh, I. Bricault, M. Capovilla, O. Pellet, … Yoann Lherm. (2017). Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study. European Journal of Surgical Oncology (EJSO), 43, 1915–1923. https://doi.org/10.1016/j.ejso.2017.05.009

Chicago

S. Velasco, M. Chassang, Laurence Gladieff, Jean-Marc Guilloit, Frédéric Dumont, Thomas Courvoisier, Magali Svrcek, et al. 2017. “Immunohistochemical Evaluation of Two Antibodies against PD-L1 and Prognostic Significance of PD-L1 Expression in Epithelioid Peritoneal Malignant Mesothelioma: A RENAPE Study.” European Journal of Surgical Oncology (EJSO) 43 (October): 1915–23. doi:10.1016/j.ejso.2017.05.009.